POPULARITY
Categories
218 episodes with md phd
86 episodes with md phd
156 episodes with md phd
160 episodes with md phd
140 episodes with md phd
206 episodes with md phd
142 episodes with md phd
64 episodes with md phd
75 episodes with md phd
65 episodes with md phd
78 episodes with md phd
40 episodes with md phd
64 episodes with md phd
46 episodes with md phd
36 episodes with md phd
47 episodes with md phd
43 episodes with md phd
46 episodes with md phd
46 episodes with md phd
25 episodes with md phd
67 episodes with md phd
35 episodes with md phd
38 episodes with md phd
50 episodes with md phd
16 episodes with md phd
36 episodes with md phd
23 episodes with md phd
24 episodes with md phd
41 episodes with md phd
43 episodes with md phd
21 episodes with md phd
34 episodes with md phd
10 episodes with md phd
38 episodes with md phd
9 episodes with md phd
26 episodes with md phd
20 episodes with md phd
21 episodes with md phd
15 episodes with md phd
16 episodes with md phd
13 episodes with md phd
25 episodes with md phd
6 episodes with md phd
15 episodes with md phd
20 episodes with md phd
22 episodes with md phd
11 episodes with md phd
10 episodes with md phd
12 episodes with md phd
8 episodes with md phd
8 episodes with md phd
7 episodes with md phd
9 episodes with md phd
6 episodes with md phd
8 episodes with md phd
15 episodes with md phd
5 episodes with md phd
4 episodes with md phd
14 episodes with md phd
5 episodes with md phd
10 episodes with md phd
13 episodes with md phd
8 episodes with md phd
6 episodes with md phd
20 episodes with md phd
6 episodes with md phd
5 episodes with md phd
5 episodes with md phd
8 episodes with md phd
6 episodes with md phd
5 episodes with md phd
6 episodes with md phd
4 episodes with md phd
8 episodes with md phd
5 episodes with md phd
6 episodes with md phd
7 episodes with md phd
5 episodes with md phd
4 episodes with md phd
11 episodes with md phd
5 episodes with md phd
10 episodes with md phd
19 episodes with md phd
6 episodes with md phd
5 episodes with md phd
4 episodes with md phd
6 episodes with md phd
9 episodes with md phd
6 episodes with md phd
5 episodes with md phd
4 episodes with md phd
15 episodes with md phd
5 episodes with md phd
5 episodes with md phd
5 episodes with md phd
5 episodes with md phd
12 episodes with md phd
4 episodes with md phd
5 episodes with md phd
4 episodes with md phd
4 episodes with md phd
16 episodes with md phd
6 episodes with md phd
3 episodes with md phd
5 episodes with md phd
4 episodes with md phd
3 episodes with md phd
6 episodes with md phd
4 episodes with md phd
12 episodes with md phd
3 episodes with md phd
4 episodes with md phd
5 episodes with md phd
4 episodes with md phd
4 episodes with md phd
2 episodes with md phd
2 episodes with md phd
2 episodes with md phd
4 episodes with md phd
4 episodes with md phd
10 episodes with md phd
2 episodes with md phd
4 episodes with md phd
3 episodes with md phd
3 episodes with md phd
9 episodes with md phd
4 episodes with md phd
68 episodes with md phd
3 episodes with md phd
3 episodes with md phd
3 episodes with md phd
4 episodes with md phd
4 episodes with md phd
2 episodes with md phd
2 episodes with md phd
In today's episode, we sat down with Kelly E. McCann, MD, PhD, and Sara Nunnery, MD, MSCI, as they shared their stories and perspectives as leading women in oncology in honor of International Women's Day, which is observed annually on March 8. Dr McCann is a breast medical oncologist in the University of California system. Dr Nunnery is a breast medical oncologist with Tennessee Oncology in Nashville.Forming the backdrop of our exclusive discussion were insights shared during the 2026 OncLive Women in Oncology event, which took place on March 5, 2026, to kick off the 43rd Annual Miami Breast Cancer Conference. In our exclusive interview, Drs McCann and Nunnery used the Women in Oncology discussion as the basis for relaying their own experiences, observations, and advice regarding setting boundaries, striving for work-life harmony, advocating for oneself, and more.
The 2GuysTalking All You Can Eat Podcast Buffet - Everything We've Got - Listen Now!
We are continuing our miniseries where we pay tribute to one of my favorite podcasts, Revisionist History, hosted by the well-known author Malcolm Gladwell. Gladwell describes Revisionist History as a podcast about things overlooked and misunderstood. There are many injuries or problems we see in the office or on the sidelines that patients, parents, coaches, and even health care professionals give a generic label or diagnosis. In some situations, it may be correct, but often things get lumped into a simple category which may lead to things not being treated or managed most effectively. This is episode 10 of this series I am affectionately calling “Revisionist Sports Medicine”, a series about things in Pediatric Sports Medicine overlooked or misunderstood. Connect with The Host! Subscribe to This Podcast Now! The ultimate success for every podcaster – is FEEDBACK! Be sure to take just a few minutes to tell the hosts of this podcast what YOU think over at Apple Podcasts! It takes only a few minutes but helps the hosts of this program pave the way to future greatness! Not an Apple Podcasts user? No problem! Be sure to check out any of the other many growing podcast directories online to find this and many other podcasts via The Podcaster Matrix! Housekeeping -- Get the whole story about Dr. Mark and his launch into this program, by listing to his "101" episode that'll get you educated, caught up and in tune with the Doctor that's in the podcast house! Listen Now! -- Interested in being a Guest on The Pediatric Sports Medicine Podcast? Connect with Mark today! Links from this Episode: -- Dr. Mark Halstead: On the Web -- On X -- Dr. Rachel Coel https://www.hawaiipacifichealth.org/kapiolani/find-a-physician/search-results/Rachel-Coel/2077 Ortho Info Sever's https://orthoinfo.aaos.org/en/diseases--conditions/severs-disease/ StatPearls Sever's https://www.ncbi.nlm.nih.gov/books/NBK441928/ Calls to the Audience Inside this Episode: -- Be sure to interact with the host, send detailed feedback via our customized form and connect via ALL of our social media platforms! Do that over here now! -- Interested in being a guest inside The Pediatric Sports Medicine Podcast with Dr. Mark? Tell us now! -- Ready to share your business, organization or efforts message with Dr. Mark's focused audience? Let's have a chat! -- Do you have feedback you'd like to share with Dr. Mark from this episode? Share YOUR perspective! Be an Advertiser/Sponsor for This Program! Tell Us What You Think! Feedback is the cornerstone and engine of all great podcast. Be sure to chime in with your thoughts, perspective sand more. Share your insight and experiences with Dr. Mark by clicking here! The Host of this Program: Mark Halstead: Dr. Mark Halstead received his medical degree from the University of Wisconsin Medical School. He stayed at the University of Wisconsin for his pediatric residency, followed by a year as the chief resident. Following residency, he completed a pediatric and adult sports medicine fellowship at Vanderbilt University. He has been an elected member to the American Academy of Pediatrics (AAP) Council on Sports Medicine and Fitness and the Board of Directors of the American Medical Society for Sports Medicine (AMSSM). He has served as a team physician or medical consultant to numerous high schools, Vanderbilt University, Belmont University, Washington University, St. Louis Cardinals, St. Louis Blues, St. Louis Athletica, and St. Louis Rams. He serves and has served on many local, regional and national committees as an advisor for sports medicine and concussions. Dr. Halstead is a national recognized expert in sport-related concussions and pediatric sports medicine. — Dr. Mark Halstead on Facebook — Dr. Mark Halstead on LinkedIn — Dr. Mark Halstead on X — Learn Why The Pediatric Sports Medicine Podcast Exists... Rachel Coel: Dr. Rachel Coel is a sports medicine physician triple board-certified in general pediatrics, sports medicine, and obesity medicine. Dr. Coel has been selected as a “Top Doctor” for HONOLULU Magazine every year since 2015. She specializes in concussion, fracture care, telemedicine, and the prevention and treatment of all sports injuries. Dr. Coel serves as a team physician for many of Hawai‘i's collegiate and high school athletes, including University of Hawai'i, Hawaii Pacific University, Kamehameha Schools, Punahou School, and Roosevelt High School. Dr. Coel enjoys teaching and is an Associate Professor of Pediatrics at the University of Hawai'i John A. Burns School of Medicine. Dr. Coel graduated with High Honors from the University of California at Berkeley and received her MD/PhD from the University of Illinois at Urbana-Champaign. She completed a general pediatrics residency at Children's Hospital Los Angeles and a sports medicine fellowship at the University of Colorado. In her free time, Dr. Coelenjoys surfing, outdoor sports, eating dessert, and spending time with her husband, children, and mischievous goldendoodle. Connect with Dr. Rachel Coe: https://www.hawaiipacifichealth.org/kapiolani/find-a-physician/search-results/Rachel-Coel/2077
Jonathan W. Goldman, MD / Misty Dawn Shields, MD, PhD - The Emerging Nuances of Extensive-Stage SCLC Treatment: Individualizing Care in the Immunotherapy Era
Jonathan W. Goldman, MD / Misty Dawn Shields, MD, PhD - The Emerging Nuances of Extensive-Stage SCLC Treatment: Individualizing Care in the Immunotherapy Era
Jonathan W. Goldman, MD / Misty Dawn Shields, MD, PhD - The Emerging Nuances of Extensive-Stage SCLC Treatment: Individualizing Care in the Immunotherapy Era
Jonathan W. Goldman, MD / Misty Dawn Shields, MD, PhD - The Emerging Nuances of Extensive-Stage SCLC Treatment: Individualizing Care in the Immunotherapy Era
Jonathan W. Goldman, MD / Misty Dawn Shields, MD, PhD - The Emerging Nuances of Extensive-Stage SCLC Treatment: Individualizing Care in the Immunotherapy Era
Jonathan W. Goldman, MD / Misty Dawn Shields, MD, PhD - The Emerging Nuances of Extensive-Stage SCLC Treatment: Individualizing Care in the Immunotherapy Era
(00:00) — Late to medicine: Chris didn't consider being a doctor until college, shaped by early family experiences with inadequate care.(01:20) — Struggling student to UC Davis: He describes a nontraditional path and surprise at earning a single college acceptance.(02:50) — “You won't amount to much”: A sixth-grade dismissal and falling in with the wrong crowd set the stage.(04:40) — Misdiagnosed and othered: Labeled with severe ADD, placed in special education, later correctly diagnosed with a comprehension disability.(06:25) — Not going the other way: He credits his mother's advocacy and a teacher, Mr. Russell, for keeping him engaged.(09:00) — College reset and new peers: A friend shares MD-PhD resources and expands his horizon.(10:35) — Outreach program to research home: A scholars program places him in a lab with a PI for four formative years.(11:50) — On DEI and mentors: He reflects on access programs and the impact of Dr. Connie Champagne.(13:50) — First OR spark: Shadowing an orthopedic surgeon shows him the excitement of patient care beyond pipetting.(15:40) — Sustaining motivation: Reframing medicine as a currency for service and asking who do I want to be?(17:50) — Community and advocacy: He discusses serving Indigenous communities and advocating on the Hill for GME in Indian country.(20:50) — Crafting the Why: How deep reflection and post-it mapping shaped his personal statement.(21:55) — Why MD-PhD: An MD-PI at a summer program shows how medical training sharpens research questions.(23:30) — First interview relief: Landing an invite during the COVID cycle felt like validation.(24:45) — Strategy and scope: 23 applications, West Coast focus, MSTP and non-MSTP programs.(26:00) — Coherence wins: A clear why plus tangible research output made his application click.(27:45) — Multiple acceptances: He recalls the emotions of earning 9–10 offers.(28:40) — To students doubting themselves: Separate self-worth from others' opinions and keep going.(31:20) — What's next: Interest in dermatology residency and leading a lab studying skin disease mechanisms.Chris never planned on medicine. Growing up in Southern California, he saw family members with preventable disease go uncared for, struggled in school, and was misdiagnosed with severe ADD in middle school before a later diagnosis of a comprehension disability. After being told in sixth grade he wouldn't amount to much, a continuation school, his mother's advocacy, and a teacher's attention kept him afloat.At UC Davis, an outreach email changed everything, placing him in a lab for four years and opening the door to both science and medicine. A friend introduced him to MD-PhD resources, and shadowing an orthopedic surgeon turned interest into excitement. Chris shares how he built an enduring motivation by reframing medicine as a currency for service, with a commitment to community, including Indigenous communities.He breaks down the hardest premed task—articulating Why Medicine—and the post-it exercise that helped him find a coherent thread. Applying during the first COVID cycle, he earned 16 interview invites and 9–10 acceptances by presenting a clear why and tangible research work. We also discuss advocacy for more GME positions in Indian country and his interest in dermatology and leading a lab.If you've ever been told you won't make it, this conversation offers practical ways to keep going.What You'll Learn:- How a misdiagnosis and school setbacks were addressed and reframed- Ways to access research and mentorship through outreach programs- A practical method to build a coherent Why Medicine- What made his MD-PhD application make sense and earn 16 interviews- Using community and advocacy to sustain motivation
How This Is Building Me, hosted by world-renowned oncologist D. Ross Camidge, MD, PhD, is a podcast focused on the highs and lows, ups and downs of all those involved with cancer, cancer medicine, and cancer science across the full spectrum of life's experiences.In this episode, Dr Camidge sat down with Tim Clackson, PhD. Dr Clackson is a biotechnology executive at Kesmalea Therapeutics.Drs Camidge and Clackson discussed Dr Clackson's career journey through the biotechnology field, which began when his innate curiosity about biology and evolution led him to study biochemistry. He then pursued his PhD and was part of the small team that developed antibody phage display libraries, a breakthrough technology that allows scientists to mimic the immune system in a test tube to find specific antibodies. This work was foundational to the discovery of major drugs and contributed to the awarding of a Nobel Prize in 2018.In 1991, Dr Clackson moved to the US to pursue a postdoc at Genentec, where he was inspired by the company's vibrant and optimistic research environment. He then joined Ariad Pharmaceuticals, where he stayed for more than 20 years, evolving from a bench scientist to president of R&D. A major highlight of his tenure was the development of ponatinib (Iclusig) for the treatment of patients with chronic myeloid leukemia. He also navigated significant challenges, including ponatinib's temporary market withdrawal due to safety concerns, which the company eventually resolved by narrowing the drug's clinical application.In the following years, Dr Clackson transitioned into chief executive officer roles at other biotech firms, such as IDRx. He noted that although acquisitions often result in leadership changes—humorously stating, "the higher you are, the quicker you go"—he enjoyed the storytelling aspect of pitching scientific strategies to investors. In the present day, Dr Clackson remains active in the biotechnology industry through board service and entrepreneurship.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/SAT865. CME/MOC/NCPD/AAPA/IPCE credit will be available until February 22, 2027.Immune Innovation in Head and Neck Cancer: Insights on Checkpoint Inhibitors and Bispecifics Across Disease Settings In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by educational grants from Bicara Therapeutics Inc., Coherus BioSciences, Inc., Johnson & Johnson, and Merus.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/WSN865. CME/MOC/AAPA/IPCE credit will be available until February 26, 2027.Smoothing the Way in Eosinophilic Esophagitis: Targeted, Team-Based Strategies for Pediatric and Adult Care In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent educational grant from Regeneron Pharmaceuticals, Inc and Sanofi.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/SAT865. CME/MOC/NCPD/AAPA/IPCE credit will be available until February 22, 2027.Immune Innovation in Head and Neck Cancer: Insights on Checkpoint Inhibitors and Bispecifics Across Disease Settings In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by educational grants from Bicara Therapeutics Inc., Coherus BioSciences, Inc., Johnson & Johnson, and Merus.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/SAT865. CME/MOC/NCPD/AAPA/IPCE credit will be available until February 22, 2027.Immune Innovation in Head and Neck Cancer: Insights on Checkpoint Inhibitors and Bispecifics Across Disease Settings In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by educational grants from Bicara Therapeutics Inc., Coherus BioSciences, Inc., Johnson & Johnson, and Merus.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/SAT865. CME/MOC/NCPD/AAPA/IPCE credit will be available until February 22, 2027.Immune Innovation in Head and Neck Cancer: Insights on Checkpoint Inhibitors and Bispecifics Across Disease Settings In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by educational grants from Bicara Therapeutics Inc., Coherus BioSciences, Inc., Johnson & Johnson, and Merus.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/SAT865. CME/MOC/NCPD/AAPA/IPCE credit will be available until February 22, 2027.Immune Innovation in Head and Neck Cancer: Insights on Checkpoint Inhibitors and Bispecifics Across Disease Settings In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by educational grants from Bicara Therapeutics Inc., Coherus BioSciences, Inc., Johnson & Johnson, and Merus.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/SAT865. CME/MOC/NCPD/AAPA/IPCE credit will be available until February 22, 2027.Immune Innovation in Head and Neck Cancer: Insights on Checkpoint Inhibitors and Bispecifics Across Disease Settings In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by educational grants from Bicara Therapeutics Inc., Coherus BioSciences, Inc., Johnson & Johnson, and Merus.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/WSN865. CME/MOC/AAPA/IPCE credit will be available until February 26, 2027.Smoothing the Way in Eosinophilic Esophagitis: Targeted, Team-Based Strategies for Pediatric and Adult Care In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent educational grant from Regeneron Pharmaceuticals, Inc and Sanofi.Disclosure information is available at the beginning of the video presentation.
PeerView Immunology & Transplantation CME/CNE/CPE Audio Podcast
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/WSN865. CME/MOC/AAPA/IPCE credit will be available until February 26, 2027.Smoothing the Way in Eosinophilic Esophagitis: Targeted, Team-Based Strategies for Pediatric and Adult Care In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent educational grant from Regeneron Pharmaceuticals, Inc and Sanofi.Disclosure information is available at the beginning of the video presentation.
PeerView Immunology & Transplantation CME/CNE/CPE Video Podcast
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/WSN865. CME/MOC/AAPA/IPCE credit will be available until February 26, 2027.Smoothing the Way in Eosinophilic Esophagitis: Targeted, Team-Based Strategies for Pediatric and Adult Care In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent educational grant from Regeneron Pharmaceuticals, Inc and Sanofi.Disclosure information is available at the beginning of the video presentation.
We have all seen the unfortunate headlines. Why are we seeing a rise of early-onset colorectal cancer and what can we do about it? Dr. Barnell, co-founder and CMO of Geneoscopy, joins the Gut Doctor Podcast to answer these questions and more!
Dr. Matt Goldstein is the CEO of JScreen, a national nonprofit making genetic testing accessible for cancer and reproductive health. A Stanford-trained MD/PhD who completed his clinical training at Harvard, Dr. Goldstein has led groundbreaking biotech ventures.His commitment to genetic awareness is deeply personal—after losing his daughter, Havi, to Tay-Sachs disease in 2021, he became a passionate advocate for proactive testing and prevention. Through JScreen, Dr. Goldstein honors Havi's legacy by helping families make informed health decisions, most recently leading the record-breaking Pink Power Hour event with NBC's TODAY Show, Mount Sinai Cancer Center, and Myriad Genetics.In This EpisodeJScreenMatt on Instagram @getjscreenedBecome a supporter of this podcast: https://www.spreaker.com/podcast/the-trauma-therapist--5739761/support.You can learn more about what I do here:The Trauma Therapist Newsletter: celebrates the people and voices in the mental health profession. And it's free! Check it out here: https://bit.ly/4jGBeSa———If you'd like to support The Trauma Therapist Podcast and the work I do you can do that here with a monthly donation of $5, $7, or $10: Donate to The Trauma Therapist Podcast.Click here to join my email list and receive podcast updates and other news.Thank you to our Sponsors:Jane App - use code GUY1MO at https://jane.appArizona Trauma Institute at https://aztrauma.org/
In today's episode, we spoke with Anne Chiang, MD, PhD, to discuss the rapidly evolving treatment landscape in small cell lung cancer (SCLC) and what this new era of innovation means for patients. Dr Chiang is an associate professor of medicine in the Section of Medical Oncology at Yale School of Medicine and associate cancer center director for clinical initiatives at Yale Cancer Center in New Haven, Connecticut.In our exclusive interview, Chiang reflected on how the field has shifted since the introduction of chemoimmunotherapy in 2018, highlighting improvements in median overall survival and the emergence of long-term responders in extensive-stage disease. Chiang also explored the growing understanding of disease heterogeneity, and the evolution of biomarker-informed strategies like under evaluation in the phase 2 S2409 PRISM trial (NCT06769126).Additionally, Chiang examined the clinical effect of DLL3-targeted therapies, including the recently approved bispecific antibody tarlatamab-dlle (Imdelltra), and how surface-targeting strategies are expanding options beyond traditional chemotherapy. Beyond efficacy, Chiang underscored the importance of individualized decision-making by assessing patient fitness beyond ECOG performance status, navigating treatment urgency in rapidly progressive disease, and balancing durability with toxicity when counseling patients on therapy.
In today's episode, we spoke with David Carbone, MD, PhD. Dr Carbone is a professor of internal medicine at The Ohio State University, co-leader of the Translational Therapeutics Program and director of the Thoracic Oncology Center at the Ohio State University Comprehensive Cancer Center–James, as well as the Barbara J. Bonner Chair in Lung Cancer Research in Columbus.In our exclusive interview, Dr Carbone discussed the 6-year data from the phase 3 CheckMate 9LA trial (NCT03215706), which not only reaffirmed the durability of benefit with nivolumab (Opdivo) plus ipilimumab (Yervoy) and chemotherapy but also highlighted particularly strong outcomes in historically poor-prognosis subgroups, including patients with PD-L1–negative tumors and those with squamous histology. Carbone also underscored the safety and tolerability of the regimen. Although dual immunotherapy carries higher toxicity than monotherapy, no new safety signals emerged at 6 years. Carbone also addressed the limitations of current biomarkers. Although PD-L1 remains the primary tool guiding immunotherapy decisions, it is an imperfect predictor.
Cristina Saura Manich, MD, PhD - First-Line Treatment of HER2-Positive Metastatic Breast Cancer: Could Investigational Approaches Improve on Current Standard of Care?
Cristina Saura Manich, MD, PhD - First-Line Treatment of HER2-Positive Metastatic Breast Cancer: Could Investigational Approaches Improve on Current Standard of Care?
Cristina Saura Manich, MD, PhD - First-Line Treatment of HER2-Positive Metastatic Breast Cancer: Could Investigational Approaches Improve on Current Standard of Care?
Cristina Saura Manich, MD, PhD - First-Line Treatment of HER2-Positive Metastatic Breast Cancer: Could Investigational Approaches Improve on Current Standard of Care?
What if Alzheimer's isn't inevitable – and your brain is far more changeable than you've been led to believe? World-renowned neurologist Dr. Majid Fotuhi shares groundbreaking research from his new book showing that cognitive decline can often be delayed, prevented, and even reversed – and how music uniquely strengthens the brain's memory, attention, and emotional networks. If you've ever wondered whether playing, singing, or even listening to music can truly keep you sharp as you age, this conversation will give you hope – and a practical path forward. Links and notes related to this episode can be found at https://mpetersonmusic.com/podcast/episode229 Connect with us: Newsletter: https://mpetersonmusic.com/subscribe Facebook: https://www.facebook.com/EnhanceLifeMusic/ Instagram: https://www.instagram.com/enhancelifemusic/ LinkedIn: https://www.linkedin.com/in/mpetersonpiano/ X: https://twitter.com/musicenhances YouTube: https://www.youtube.com/@enhancelifemusic Sponsorship information: https://mpetersonmusic.com/podcast/sponsor Leave us a review on Podchaser.com! https://www.podchaser.com/podcasts/enhance-life-with-music-909096 In-episode promo: MUD/WTR (https://mudwtr.com/ENHANCELIFE)
PeerView Family Medicine & General Practice CME/CNE/CPE Video Podcast
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/SHS865. CME/MOC/NCPD/AAPA/IPCE credit will be available until February 28, 2027.Preparing for the New Era of Blood-Based Biomarkers in Alzheimer's Disease: Navigating Guidelines, Understanding Policy, and Integrating Into Practice Workflows In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/SHS865. CME/MOC/NCPD/AAPA/IPCE credit will be available until February 28, 2027.Preparing for the New Era of Blood-Based Biomarkers in Alzheimer's Disease: Navigating Guidelines, Understanding Policy, and Integrating Into Practice Workflows In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.
PeerView Neuroscience & Psychiatry CME/CNE/CPE Audio Podcast
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/SHS865. CME/MOC/NCPD/AAPA/IPCE credit will be available until February 28, 2027.Preparing for the New Era of Blood-Based Biomarkers in Alzheimer's Disease: Navigating Guidelines, Understanding Policy, and Integrating Into Practice Workflows In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.
PeerView Neuroscience & Psychiatry CME/CNE/CPE Video Podcast
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/SHS865. CME/MOC/NCPD/AAPA/IPCE credit will be available until February 28, 2027.Preparing for the New Era of Blood-Based Biomarkers in Alzheimer's Disease: Navigating Guidelines, Understanding Policy, and Integrating Into Practice Workflows In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/SHS865. CME/MOC/NCPD/AAPA/IPCE credit will be available until February 28, 2027.Preparing for the New Era of Blood-Based Biomarkers in Alzheimer's Disease: Navigating Guidelines, Understanding Policy, and Integrating Into Practice Workflows In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/SHS865. CME/MOC/NCPD/AAPA/IPCE credit will be available until February 28, 2027.Preparing for the New Era of Blood-Based Biomarkers in Alzheimer's Disease: Navigating Guidelines, Understanding Policy, and Integrating Into Practice Workflows In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.
PeerView Family Medicine & General Practice CME/CNE/CPE Audio Podcast
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/SHS865. CME/MOC/NCPD/AAPA/IPCE credit will be available until February 28, 2027.Preparing for the New Era of Blood-Based Biomarkers in Alzheimer's Disease: Navigating Guidelines, Understanding Policy, and Integrating Into Practice Workflows In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/SHS865. CME/MOC/NCPD/AAPA/IPCE credit will be available until February 28, 2027.Preparing for the New Era of Blood-Based Biomarkers in Alzheimer's Disease: Navigating Guidelines, Understanding Policy, and Integrating Into Practice Workflows In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.
Send a textDr. Sheri Fink, Pulitzer Prize-winning correspondent for The New York Times and author of Five Days at Memorial, joins us for a compelling discussion on the ethics of survival. Dr. Fink, an MD-PhD, discusses her recent article "Noah is Still Here," which chronicles one family's journey with Trisomy 18—a condition once universally deemed incompatible with life. She and Eli explore the shifting paradigms of care, the tension between medical prognosis and parental hope, and the "two truths" clinicians must hold when counseling families in the grey zone. A must-listen for anyone navigating complex bioethics in the NICU. Support the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below. Enjoy!
In today's episode, we spoke with Alexander I. Spira, MD, PhD, FACP, FASCO. Dr Spira is co-director of the Virginia Cancer Specialists (VCS) Research Institute in Fairfax, director of the VCS Thoracic and Phase I Program, chief scientific officer of NEXT Oncology, and a clinical assistant professor at Johns Hopkins University in Baltimore, Maryland.In our exclusive interview, Dr Spira discussed the significance of the December 2025 FDA approval of amivantamab and hyaluronidase-lpuj (Rybrevant Faspro), also known as subcutaneous amivantamab, for the treatment of patients with EGFR-mutated non–small cell lung cancer (NSCLC) across all approved indications for amivantamab-vmjw (Rybrevant). He noted key data from the pivotal phase 3 PALOMA-3 trial (NCT05388669), which showed that subcutaneous amivantamab combined with lazertinib (Lazcluze) had a more favorable safety profile compared with intravenous (IV) amivantamab plus lazertinib and was noninferior to the IV formulation in terms of efficacy. Dr Spira contextualized these trial findings within the larger EGFR-mutated NSCLC treatment paradigm and explained how this formulation of amivantamab addresses a previously unmet patient need.
How This Is Building Me, hosted by world-renowned oncologist D. Ross Camidge, MD, PhD, is a podcast focused on the highs and lows, ups and downs of all those involved with cancer, cancer medicine, and cancer science across the full spectrum of life's experiences.In this episode, Dr Camidge sat down with Robert Kantor, MD. Dr Kantor is associate medical director of Medical Oncology & Hematology at Private Health Management.Drs Camidge and Kantor reflected on Dr Kantor's decades-long career. Inspired by his father's devotion to patients, Dr Kantor fast-tracked his education, entering medical school at Wayne State University without completing an undergraduate degree. Following fellowship, he intentionally chose private practice over academic oncology to focus on direct patient care and making a difference in the lives of patients' families.Dr Kantor's career illustrates the shifting landscape of American medicine. He has navigated various oncology practice models, including a corporate merger that he felt compromised patient care. In 2008, he took the risk of launching his own solo practice, successfully bringing trusted staff and a dedicated patient base with him.Dr Kantor eventually retired from clinical practice due to burnout, which was exacerbated by corporate management challenges and the inefficiencies of electronic medical records. His retirement evolved into an "encore career" as an associate medical director for Private Health Management. In this consultative role, he provides clinical oversight for complex oncology cases, helping patients navigate toward personalized cancer vaccines, clinical trials, and cutting-edge therapies. Dr Kantor expressed that this work has brought him renewed enthusiasm for the field of oncology, as it allows him to use his decades of experience with a basis of a better work-life balance. He remains passionate about how these high-end, personalized technologies will eventually make their way into routine clinical practice to benefit the broader patient population.
Struggling with the AMCAS Work & Activities (Experiences) section and the Most Meaningful entries? In this episode of the Jack Westin Pre-Med Admissions Podcast, Dr. Anita Paschal (MD, double PhD, 30+ years on medical school admissions committees) breaks down exactly how admissions committees evaluate your 15 AMCAS experiences, your 700-character descriptions, and your 3 Most Meaningful (1,325 characters) sections.You'll learn:
In this episode of the Gut Doctor podcast, Dr. Parikh discusses the current treatment landscape of constipation with Dr. Satish Rao. Dr. Rao is Chair of Gastroenterology, Professor of Medicine, and Director of Neurogastroenterology and Motility at August University. This episode was sponsored by Vibrant Gastro, makers of the drug-free Vibrant System.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/KNB865. CME/AAPA/IPCE credit will be available until February 22, 2027.Alzheimer's Disease Case Conference: Building Confidence in Visual Interpretation and Quantitative Analysis of Neuroimaging In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/BGV865. CME credit will be available until February 11, 2027.Staying Current on Immunotherapy for HNSCC: Conversations on Clinical Collaboration and Treatment Selection In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc.Disclosure information is available at the beginning of the video presentation.
PeerView Neuroscience & Psychiatry CME/CNE/CPE Audio Podcast
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/KNB865. CME/AAPA/IPCE credit will be available until February 22, 2027.Alzheimer's Disease Case Conference: Building Confidence in Visual Interpretation and Quantitative Analysis of Neuroimaging In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/BGV865. CME credit will be available until February 11, 2027.Staying Current on Immunotherapy for HNSCC: Conversations on Clinical Collaboration and Treatment Selection In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc.Disclosure information is available at the beginning of the video presentation.
PeerView Neuroscience & Psychiatry CME/CNE/CPE Video Podcast
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/KNB865. CME/AAPA/IPCE credit will be available until February 22, 2027.Alzheimer's Disease Case Conference: Building Confidence in Visual Interpretation and Quantitative Analysis of Neuroimaging In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation.
#689: Most people think forgetting a name means their brain is failing. Dr. Majid Fotuhi, a neurologist who taught at Johns Hopkins and Harvard, sees thousands of patients convinced they have Alzheimer's – only to discover they're dealing with poor sleep or stress. Dr. Fotuhi joins us to break down the difference between cognitive decline, dementia and Alzheimer's disease. He explains why chronic stress physically shrinks your hippocampus — the thumb-sized memory center in your brain — and how twelve weeks of lifestyle changes reversed cognitive decline in 84 percent of his patients. We talk about the five hidden taxes draining your brain: sedentary lifestyle, poor sleep, junk food, chronic stress and mental laziness. Scrolling social media after work counts as mental laziness, even if your day job involves intense focus. Dr. Fotuhi offers a different framework: five pillars that compound over time. Exercise ranks first because it multiplies mitochondria in your brain cells, reduces inflammation and generates new neurons in your hippocampus. Walking 10,000 steps daily cuts Alzheimer's risk by 50 percent. Sleep comes second. Your brain rinses itself during deep sleep, flushing out amyloid — the core protein in Alzheimer's disease. One night of poor sleep increases amyloid in your brain. We cover nutrition (skip the junk food debate), mindset (heart rate variability breathing reduces Alzheimer's footprints) and brain training. Dr. Fotuhi memorizes 70 names in a single lecture and explains his technique for remembering credit card numbers using mental imagery. The conversation covers London taxi drivers who grew their hippocampus by memorizing 10,000 streets, why stress management beats supplements, and how Swedish students learning Arabic increased their brain volume in three months. Timestamps: Note: Timestamps will vary on individual listening devices based on dynamic advertising segments. The provided timestamps are approximate and may be several minutes off due to changing ad lengths. (00:00) Defining cognitive decline, dementia and Alzheimer's disease (05:19) Why cognitive issues don't always mean Alzheimer's (07:24) Thinking of your brain as an asset to manage (07:51) The five hidden taxes draining your brain (10:45) How poor sleep prevents brain rinsing and causes inflammation (14:20) Oral health and brain health connection (16:40) Brain plasticity and the Broca lobe (27:02) The five pillars of brain health (35:23) Cardiovascular fitness versus strength training for brain health (38:51) Sleep as the second pillar of brain health (48:05) When exercise beats sleep (51:33) Different types of intelligence beyond IQ tests (1:03:53) Reversing brain damage from decades of bad habits (1:10:25) Nutrition and avoiding junk food (1:25:09) Mindset and stress management as pillar four (1:33:35) Breathing exercises for stress reduction (1:39:24) Brain training as the fifth pillar (1:51:52) Memory techniques for names and numbers (2:02:46) Nootropics and supplements for brain health Learn more about your ad choices. Visit podcastchoices.com/adchoices
Back to Where It All Begins: The Journey of Dr. Jason HauaIn this episode of The Pediatric Lounge podcast, hosts George and Jason introduce Dr. Jason Haua, who shares his unique career story of moving from leading a large, successful independent practice back to solo practice, focusing on mental health and autism. Dr. Haua discusses the importance of finding joy and fulfillment in medical practice, the challenges and benefits of running a smaller practice, and his reasons for stepping away from a larger organizational structure. The conversation explores the intricacies of managing a solo practice, dealing with insurance and administrative challenges, and the importance of maintaining a positive work culture. Dr. Haua also shares insights on legacy planning, practice efficiency, and the evolving landscape of pediatric care.00:00 Introduction to The Pediatric Lounge01:00 Meet Dr. Jason Haua: A Journey Back to Solo Practice01:42 The Philosophy of Returning to Solo Practice03:24 Building and Managing a Successful Practice07:17 Challenges and Rewards of Mental Health Focus08:30 Operational Efficiency in a Small Practice16:10 Transitioning from Large Group to Solo Practice20:36 The Role of Technology and Personal Touch39:46 Future Plans and Legacy41:44 Balancing Work and Personal Life42:44 Challenges of Starting a Medical Practice44:43 Financial Struggles in Pediatrics46:27 The Cost of Medical Equipment and Supplies48:21 Navigating Insurance and Billing Issues01:13:07 The Role of Optimism in Professional and Personal Life01:15:31 Conclusion and Final ThoughtsSupport the show
This week we welcome back our resident reproductive endocrinologist and menopause specialist, Dr. Carla DiGirolamo, for another candid conversation. We pull back the curtain on Carla's own menopause experience—how she navigates her symptoms, what she's learned, and what she practices herself. We also dig into the hard conversations so many of us are having as we navigate this ever-evolving space, and how years of working closely with active midlife women have shaped her thinking on hormone therapy, GLP-1 medications, testosterone, hormone testing, and what actually moves the needle for athletic women in the transition.Carla DiGirolamo, MD, PhD, is a Double Board Certified Reproductive Endocrinologist and Obstetrician/Gynecologist specializing in women's performance and menopausal medicine. She is also a Crossfit Level 1 trainer, Certified Nutrition Coach, and member of CrossFit Medical Society. She is a MedFit Care provider and provides weekly workouts and medical updates at her Substack Athletic Aging. She is an Endocrine Consultant for Wild Health and Women's Health Director at Eternal Health. Most recently, she has launched her own private practice specializing in helping active and high-performing women reach their performance potential from puberty through menopause. Dr. DiGirolamo is now seeing patients for virtual consultations for menopausal care and performance optimization. Visit her website www.drcarlad.com to learn more about her services and schedule an appointment.ResourcesAthletic Aging with Dr. Carla DiGirolamo on SubstackSign up for our FREE Feisty 40+ newsletter: https://feisty.co/feisty-40/Feisty Strong Retreat, April 17-19, 2026 - Atlanta https://feisty.co/events/feisty-strong-retreat-atlanta/Learn More about our 2026 Feisty Events, including Bike Camps and Cycling Trips: https://feisty.co/events/Follow Us on Instagram:Feisty Menopause: @feistymenopauseHit Play Not Pause Facebook Group: https://www.facebook.com/groups/807943973376099Support our Partners:Midi Health: You Deserve to Feel Great. Book your virtual visit today at https://www.joinmidi.com/Cozy Earth: Use Code HITPLAY at https://cozyearth.com/ for up to 20% offHettas: Use code STAYFEISTY for 20% off at https://hettas.com/ Previnex: Get 15% off your first order with code HITPLAY at https://www.previnex.com/
© 2020-2026 Ivy Podcast Discovery LLC
